A recent report from MarketsAndMarkets projected that the global gastric cancer market accounted for USD 3.01 billion in 2023 and is expected to reach USD 18.43 billion by 2034 with a CAGR of 17.92% ...

Learn about stomach cancer symptoms, causes, and treatments. Understand risk factors and prevention to reduce your chances of ...

Patients with locally advanced gastric cancers saw complete response rates of 18.3% from camrelizumab and rivoceranib plus ...

Platinum (cisplatin and oxaliplatin), taxanes (paclitaxel and docetaxel) and irinotecan are active agents used to treat gastric cancer. Based on the efficacy and tolerability of capecitabine ...

Stomach cancer often shows no early signs, and when symptoms do appear, they are frequently overlooked. This makes prevention ...

This page includes links to articles highlighting the top gastrointestinal cancer research published on Cancer Therapy ...

Stephanie Thomas was diagnosed with terminal cancer after being removed from the patient list at her local GP after repeated ...

The functions of microvesicles (MVs) in gastric cancer are less studied compared to other types of extracellular vesicles. Here, the authors report that in Epstein-Barr virus (EBV)-associated ...

Gastric cancer is the fifth most common cancer among men and seventh most common cancer ... Agilus Diagnostics is thrilled to bring this advanced tool to India and support oncologists and patients in ...